[Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
Sippell
W G
WG
Universitäts-Kinderklinik Kiel.
Partsch
C J
CJ
Hümmelink
R
R
Lorenzen
F
F
D000728:Androgens / Q000097:blood; D001846:Bone Development / Q000187:drug effects; D001940:Breast / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006128:Growth / Q000187:drug effects; D006801:Humans; D008186:Luteolytic Agents / Q000627:therapeutic use*; D011629:Puberty, Precocious / Q000188:drug therapy*; D017329:Triptorelin Pamoate
D000728:Androgens; D003692:Delayed-Action Preparations; D008186:Luteolytic Agents; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone
Langzeittherapie mit dem Retard-LHRH-Agonisten Decapeptyl-Depot bei Mädchen mit Pubertas praecox vera. Ergebnisse einer internationalen Multizenterstudie.